Literature DB >> 15270687

Translation inhibition during the induction of apoptosis: RNA or protein degradation?

M Bushell1, M Stoneley, P Sarnow, A E Willis.   

Abstract

The induction of apoptosis leads to a substantial inhibition of protein synthesis. During this process changes to the translation-initiation factors, the ribosome and the cellular level of mRNA have been documented. However, it is by no means clear which of these events are necessary to achieve translational shutdown. In this article, we discuss modifications to the translational apparatus that occur during apoptosis and examine the potential contributions that they make to the inhibition of protein synthesis. Moreover, we present evidence that suggests that a global increase in the rate of mRNA degradation occurs before the caspase-dependent cleavage of initiation factors. Increased mRNA decay is temporally correlated with the shutdown of translation and therefore plays a major role in the inhibition of protein synthesis in apoptotic cells.

Mesh:

Substances:

Year:  2004        PMID: 15270687     DOI: 10.1042/BST0320606

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  14 in total

1.  KHDC1A, a novel translational repressor, induces endoplasmic reticulum-dependent apoptosis.

Authors:  Congli Cai; Jing Liu; Chao Wang; Jinhua Shen
Journal:  DNA Cell Biol       Date:  2012-06-25       Impact factor: 3.311

2.  Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton.

Authors:  Ozanna Burnicka-Turek; Aleksandra Kata; Byambajav Buyandelger; Linda Ebermann; Nadine Kramann; Peter Burfeind; Sigrid Hoyer-Fender; Wolfgang Engel; Ibrahim M Adham
Journal:  BMC Cell Biol       Date:  2010-04-20       Impact factor: 4.241

3.  Global cellular response to chemotherapy-induced apoptosis.

Authors:  Arun P Wiita; Etay Ziv; Paul J Wiita; Anatoly Urisman; Olivier Julien; Alma L Burlingame; Jonathan S Weissman; James A Wells
Journal:  Elife       Date:  2013-10-29       Impact factor: 8.140

4.  Systems Biology Strategy Reveals PKCδ is Key for Sensitizing TRAIL-Resistant Human Fibrosarcoma.

Authors:  Kentaro Hayashi; Sho Tabata; Vincent Piras; Masaru Tomita; Kumar Selvarajoo
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

5.  Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics.

Authors:  Maximilian W Popp; Lynne E Maquat
Journal:  Nat Commun       Date:  2015-03-26       Impact factor: 14.919

6.  Apoptosis Triggers Specific, Rapid, and Global mRNA Decay with 3' Uridylated Intermediates Degraded by DIS3L2.

Authors:  Marshall P Thomas; Xing Liu; Jennifer Whangbo; Geoffrey McCrossan; Keri B Sanborn; Emre Basar; Michael Walch; Judy Lieberman
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

Review 7.  Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.

Authors:  Florent Morfoisse; Edith Renaud; Fransky Hantelys; Anne-Catherine Prats; Barbara Garmy-Susini
Journal:  Mol Cell Oncol       Date:  2015-05-27

Review 8.  Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.

Authors:  Florent Morfoisse; Edith Renaud; Fransky Hantelys; Anne-Catherine Prats; Barbara Garmy-Susini
Journal:  Mol Cell Oncol       Date:  2014-08-13

9.  Comparative sequence analysis of the complete set of 40S ribosomal proteins in the Senegalese sole (Solea senegalensis Kaup) and Atlantic halibut (Hippoglossus hippoglossus L.) (Teleostei: Pleuronectiformes): phylogeny and tissue- and development-specific expression.

Authors:  Manuel Manchado; Carlos Infante; Esther Asensio; Jose Pedro Cañavate; Susan E Douglas
Journal:  BMC Evol Biol       Date:  2007-07-03       Impact factor: 3.260

10.  A gastrin transcript expressed in gastrointestinal cancer cells contains an internal ribosome entry site.

Authors:  A M Grabowska; C A Berry; J Hughes; M Bushell; A E Willis; S A Watson
Journal:  Br J Cancer       Date:  2008-04-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.